Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: LarryS who wrote (10721)	7/10/1999 6:43:00 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Larry, wasn't that quote on Yahoo from the inventor of the internet and your next president....... Al Gore? LOL

To: LarryS who wrote (10721)	7/10/1999 11:44:00 PM
From: aknahow	Respond to of 17367

I would think the un blinding of the data, even if that is not until August 13, would stimulate any parties interested in Mycoprex to move faster. The fact that Allergan partnered for rBPI21, is another reason I would think the heat would be on. XOMA indicates there are several parties looking at Mycoprex. What do you tell your boss if someone else makes the deal and a blockbuster drug is produced? But none of the above guarantees there will be a deal. If there is one it could be several magnitudes larger than the Allergan deal. Perhaps 4 to 9 times as large. My reasoning for this is it seems the $11 million was considered small potatoes and the market for a powerful fungicide that works is huge.